CTE Stock Overview
Provides outsourced clinical trials logistic services in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Cryosite Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.85 |
| 52 Week High | AU$1.25 |
| 52 Week Low | AU$0.58 |
| Beta | 0.37 |
| 1 Month Change | -0.58% |
| 3 Month Change | 6.25% |
| 1 Year Change | 39.34% |
| 3 Year Change | 91.01% |
| 5 Year Change | 1,503.77% |
| Change since IPO | 93.19% |
Recent News & Updates
Recent updates
Cryosite (ASX:CTE) Is Due To Pay A Dividend Of A$0.02
Aug 22
With A 31% Price Drop For Cryosite Limited (ASX:CTE) You'll Still Get What You Pay For
Aug 20Calculating The Intrinsic Value Of Cryosite Limited (ASX:CTE)
Jul 23Cryosite Limited's (ASX:CTE) 33% Jump Shows Its Popularity With Investors
May 09Subdued Growth No Barrier To Cryosite Limited's (ASX:CTE) Price
Feb 02Do Cryosite's (ASX:CTE) Earnings Warrant Your Attention?
Feb 07Should You Be Adding Cryosite (ASX:CTE) To Your Watchlist Today?
Aug 19Do Cryosite's (ASX:CTE) Earnings Warrant Your Attention?
May 02Shareholder Returns
| CTE | AU Life Sciences | AU Market | |
|---|---|---|---|
| 7D | 0% | 0.6% | -2.0% |
| 1Y | 39.3% | 12.0% | 7.8% |
Return vs Industry: CTE exceeded the Australian Life Sciences industry which returned 12% over the past year.
Return vs Market: CTE exceeded the Australian Market which returned 7.8% over the past year.
Price Volatility
| CTE volatility | |
|---|---|
| CTE Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 8.9% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.8% |
| 10% least volatile stocks in AU Market | 3.1% |
Stable Share Price: CTE's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: Insufficient data to determine CTE's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 25 | n/a | www.cryosite.com |
Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through two segments: Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment offers specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological, and cell gene therapies depot services.
Cryosite Limited Fundamentals Summary
| CTE fundamental statistics | |
|---|---|
| Market cap | AU$41.49m |
| Earnings (TTM) | AU$1.84m |
| Revenue (TTM) | AU$12.61m |
22.5x
P/E Ratio3.3x
P/S RatioIs CTE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CTE income statement (TTM) | |
|---|---|
| Revenue | AU$12.61m |
| Cost of Revenue | AU$4.62m |
| Gross Profit | AU$7.99m |
| Other Expenses | AU$6.15m |
| Earnings | AU$1.84m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.038 |
| Gross Margin | 63.38% |
| Net Profit Margin | 14.59% |
| Debt/Equity Ratio | 0% |
How did CTE perform over the long term?
See historical performance and comparisonDividends
2.4%
Current Dividend Yield53%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 01:39 |
| End of Day Share Price | 2024/12/17 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cryosite Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|